• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIANG Yan, XING Rong, LIU Jiali, MAO Yong, FU Hanxu, XIE Lin, WANG Guangji. Advances of novel technologies and theories in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2014, 45(6): 607-616. DOI: 10.11665/j.issn.1000-5048.20140601
Citation: LIANG Yan, XING Rong, LIU Jiali, MAO Yong, FU Hanxu, XIE Lin, WANG Guangji. Advances of novel technologies and theories in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2014, 45(6): 607-616. DOI: 10.11665/j.issn.1000-5048.20140601
shu

Advances of novel technologies and theories in pharmacokinetic research

More Information
    Graphical Abstract
    • Abstract
  • In recent years, new theories and new methods of pharmacokinetics are constantly emerging due to the progress of technology and research approaches. At present, the objective and content of pharmacokinetic research are extended to from the macro levels(plasma and tissue)to micro levels(cellular pharmacokinetics)gradually, and extended from single drug(western medicine)to complex components(traditional Chinese medicine). Importantly, the pharmacokinetic research is also expanded from single target to multiple targets metabolomics(or overall regulation of endogenous substances). This paper describes the latest progress of pharmacokinetics in cellular pharmacokinetics, pharmacokinetics of traditional Chinese medicine, and metabolomics.
    • FullText(HTML)
    • References (54)
  • [1]
    Andersen CA, Perfetti P, Nibbio M, et al. Brain penetration assessment in vivo:a reliable and simple method in anesthetized rats at steady state[J].J Neurosci Methods,2014,232:199-206.doi: 10.1016/j.jneumeth.2014.04.022.
    [2]
    Lee WH,Loo CY,Young PM,et al.Recent advances in curcumin nanoformulation for cancer therapy[J].Expert Opin Drug Deliv,2014,11(8):1 183-1 201.
    [3]
    Yang KY,Lin LC,Tseng TY,et al.Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS[J].J Chromatogr B Anal Technol Biomed Life Sci,2007,853(1/2):183-189.
    [4]
    Carcaboso AM, Elmeliegy MA, Shen J, et al. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas[J].Cancer Res,2010,70(11):4 499-4 508.
    [5]
    Wang Y, Liu J, Zhang J, et al. A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs[J].Int J Med Sci,2014,11(5):479-487.
    [6]
    DellaValle DM,Vandenberg A,Glahn RP.Seed coat removal improves iron bioavailability in cooked lentils:studies using an in vitro digestion/Caco-2 cell culture model[J].J Agric Food Chem,2013,61(34):8 084-8 089.
    [7]
    Guo D,Zhao Y,Zhang Y,et al.The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells[J].J Biomed Nanotechnol,2014,10(4):669-678.
    [8]
    Yu Y,Liu L,Wang X,et al.Modulation of glucagon-like peptide-1 release by berberine:in vivo and in vitro studies[J].Biochem Pharmacol,2010,79(7):1 000-1 006.
    [9]
    Morisaki T,Hou XL,Takahashi K,et al.Baicalin pharmacokinetic profile of absorption process using novel in-vitro model:cytochrome P450 3A4-induced Caco-2 cell monolayers combined with rat intestinal rinse fluids[J].J Pharm Pharmacol,2013,65(10):1 526-1 535.
    [10]
    Zhou F,Zhang J,Li P,et al.Toward a new age of cellular pharmacokinetics in drug discovery[J].Drug Metab Rev,2011,43(3):335-345.
    [11]
    Goh GY,Huang H,Ullman J,et al.Presynaptic regulation of quantal size:K+/H+ exchange stimulates vesicular glutamate transport[J].Nat Neurosci,2011,14(10):1 285-1 292.
    [12]
    Li M,Zhang J,Feng L,et al.The in vitro anti-tumor efficacy and the pharmacokinetics of N3-o-toluyl-fluorouracil loaded nanosuspension(TFu-LNS)[J].J Biomed Nanotechnol,2013,9(5):801-810.
    [13]
    Ciaparrone M,Quirino M,Schinzari G,et al.Predictive role of thymidylate synthase,dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil[J].Oncology,2006,70(5):366-377.
    [14]
    Michael M,Doherty MM.Tumoral drug metabolism:overview and its implications for cancer therapy[J].J Clin Oncol,2005,23(1):205-229.
    [15]
    Michael M, Doherty MM. Drug metabolism by tumours: its nature,relevance and therapeutic implications[J].Expert Opin Drug Metab Toxicol,2007,3(6):783-803.
    [16]
    Roy P,Waxman DJ.Activation of oxazaphosphorines by cytochrome P450:application to gene-directed enzyme prodrug therapy for cancer[J].Toxicol In Vitro,2006,20(2):176-186.
    [17]
    Perez-Tomas R.Multidrug resistance:retrospect and prospects in anti-cancer drug treatment[J].Curr Med Chem,2006,13(16):1 859-1 876.
    [18]
    Shen F, Chu S, Bence AK, et al. Quantitation of doxorubicin uptake,efflux,and modulation of multidrug resistance(MDR)in MDR human cancer cells[J].J Pharmacol Exp Ther,2008,324(1):95-102.
    [19]
    Shen F,Bailey BJ,Chu S,et al.Dynamic assessment of mitoxantrone resistance and modulation of multidrug resistance by valspodar(PSC833)in multidrug resistance human cancer cells[J].J Pharmacol Exp Ther,2009,330(2):423-429.
    [20]
    Cihalova D,Hofman J,Ceckova M,et al.Purvalanol A,olomoucine II and roscovitine inhibit ABCB1 transporter and synergistically potentiate cytotoxic effects of daunorubicin in vitro[J].PLoS One,2013,8(12):e83467.
    [21]
    Zhang J,Zhou F,Lu M,et al.Pharmacokinetics-pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic-pharmacodynamic strategy[J].Curr Drug Metab,2012,13(5):558-576.
    [22]
    Zhang J,Zhou F,Wu X,et al.20(S)-ginsenoside Rh2 noncompetitively inhibits P-glycoprotein in vitro and in vivo:a case for herb-drug interactions[J].Drug Metab Dispos,2010,38(12):2 179-2 187.
    [23]
    Zhang J,Zhou F,Niu F,et al.Stereoselective regulations of P-glycoprotein by ginsenoside Rh2 epimers and the potential mechanisms from the view of pharmacokinetics[J].PLoS One,2012,7(4):e35768.
    [24]
    Hao G,Zhou F,Liu JL.The protective effect and antioxidant mechanisms of 23-hydroxylbetulinic acid on doxorubicin-induced myocardial injury in H9c2 cell[J].Chin J Clin Pharmacol Ther(中国临床药理学与治疗学),2012,17(7):736-743.
    [25]
    Kommareddy S,Amiji M.Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice[J].J Pharm Sci,2007,96(2):397-407.
    [26]
    Lammers T,Kiessling F,Hennink WE,et al.Drug targeting to tumors:principles,pitfalls and(pre-)clinical progress[J].J Control Release,2012,161(2):175-187.
    [27]
    Ong SM,Zhao Z,Arooz T,et al.Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies[J].Biomaterials,2010,31(6):1 180-1 190.
    [28]
    Elliott NT,Yuan F.A review of three-dimensional in vitro tissue models for drug discovery and transport studies[J].J Pharm Sci,2011,100(1):59-74.
    [29]
    Nyga A,Cheema U,Loizidou M.3D tumour models:novel in vitro approaches to cancer studies[J].J Cell Commun Signal,2011,5(3):239-248.
    [30]
    Delehanty JB,Boeneman K,Bradburne CE,et al.Peptides for specific intracellular delivery and targeting of nanoparticles:implications for developing nanoparticle-mediated drug delivery[J].Ther Deliv,2010,1(3):411-433.
    [31]
    Li X, Li P, Zhang Y, et al. Novel mixed polymeric micelles for enhancing delivery of anticancer drug and overcoming multidrug resistance in tumor cell lines simultaneously[J].Pharm Res,2010,27(8):1 498-1 511.
    [32]
    Chen Y, Bathula SR, Li J, et al. Multifunctional nanoparticles delivering small interfering RNA and doxorubicin overcome drug resistance in cancer[J].J Biol Chem,2010,285(29):22 639-22 650.
    [33]
    Lu WI,Lu DP.Impact of Chinese herbal medicine on American society and health care system:perspective and concern[J].Evid Based Complement Alternat Med,2014:251891.doi: 10.1155/2014/251891.
    [34]
    Tsai WH,Yang CC,Li PC,et al.Therapeutic potential of traditional Chinese medicine on inflammatory diseases[J].J Tradit Complement Med,2013,3(3):142-151.
    [35]
    Qi LW,LExperiment-originated variations,and multi-peak and multi-origination phenomena in derivatization-based GC-MS metabolomics[J].Trac-Trends Anal Chem,2010,29(3):269-280.
    [36]
    Lindon JC,Nicholson JK,Holmes E.Non-linear methods for the analysis of metabolic profiles[M].Handbook Metabonomics Metabolomics,2011:201.
    [37]
    Zhang AH,Sun H,Yan GL,et al.Metab卯遬奯孭孩扣s study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods[J].J Physiol Biochem,2014,70(1):117-128.
    [38]
    Li MJ,Wang XF,Aa Y,<乩嘾孥驴攠剡孬朼弯i>.GC/TOFMS analysis of metabolites in serum and urine reveals metabolic perturbation of TCA cycle in db/db mice involved in diabetic nephropathy[J].Am J Physiol Renal Physiol,2013,304(11):F1 317-F1 324.
    [39]
    Lu Y,Aa J,Wang G,et al.Gas chromatography/time-of-flight mass spectrometry based metabonomic approach to differentiating hypertension- and age-related metabolic variation in spontaneously hypertensive rats[J].Rapid Commun Mass Spectrom,2008,22(18):2 882-2 888.
    [40]
    Hamanaka RB,Chandel NS.Targeting glucose metabolism for cancer therapy[J].J Exp Med,2012,209(2):211-215.
    [41]
    Chen JL,Fan J,Lu XJ.CE-MS based on moving reaction boundary method for urinary metabolomic analysis of gastric cancer patients[J].Electrophoresis,2014,35(7):1 032-1 039.
    [42]
    Aa JY,Yu LZ,Sun M,et al.Metabolic features of the tumor microenvironment of gastric cancer and the link to the systemic macroenvironment[J].Metabolomics,2012,8(1):164-173.
    [43]
    Cheng ML,Shiao MS,Chiu DTY,et al.Biochemical disorders associated with antiproliferative effect of dehydroepiandrosterone in hepatoma cells as revealed by LC-based metabolomics[J].Biochem Pharmacol,2011,82(11):1 549-1 561.
    [44]
    Zhang Q,Wang GJ,Aa JY,et al.Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba 乥噸奴煲荡牣t on diet-induced hyperlipidemia in rats[J].Acta Pharmacol Sin,2009,30(12):1 674-1 687.
    [45]
    Aa JY,Shao F,Wang GJ,et al.Gas chromatography time-of-flight mass spectrometry based metabolomic approach to evaluating toxicity of triptolide[J].Metabolomics,2011,7(2):217-225.
    [46]
    Aa JY,Qian SX,Wang GJ,et al.Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses[J].PLoS One,2010,5(10):e13186.doi:10.1371/journal.pone.0013186.lti-platform metabolomic analyses of ergosterol-induced dynamic changes in Nicotiana tabacum cells[J].PLoS One,2014,9(1):e87846.
    [47]
    Albrecht E,Waldenberger M,Krumsiek J,et al.Metabolite profiling reveals new insights into the regulation of serum urate in humans[J].Metabolomics,2014,10(1):141-151.
    [48]
    Zhao D,Han L,He Z,et al.Identification of the plasma metabolomics as early diagnostic markers between biliary atresia and neonatal hepatitis syndrome[J].PLoS One,2014,9(1):e85694.
    [49]
    Nicholson JK,Lindon JC.Systems biology—metabonomics[J].Nature,2008,455(7 216):1 054-1 056.
    [50]
    Liu LS,Aa JY,Wang GJ,et al.Differences in metabolite profile between blood plasma and serum[J].Anal Biochem,2010,406(2):105-112.
    [51]
    Gonzalez-Covarrubias V,Dane A,Hankemeier T,et al.The influence of citrate,EDTA,and heparin anticoagulants to human plasma LC-MS lipidomic profiling[J].Metabolomics,2012,9(2):337-348.
    [52]
    Álvarez-Sánchez B, Priego-Capote F, Luque de Castro MD.Metabolomics analysis II.Preparation of biological samples prior to detection[J].Trac-Trends Anal Chem,2010,29(2):120-127.
    [53]
    Lindon JC,Nicholson JK.Analytical technologies for metabonomics and metabolomics,and multi-omic information recovery[J].Trac-Trends Anal Chem,2008,27(3):194-204.
    [54]
    Xu F,Zou L,Ong CN,et al.
    • Related Articles

  • Related Articles

    [1]CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002
    [2]JIANG Xiaomei, LIU Chong. Neuroprotective effect of glycyrrhizin on diabetic retinopathy[J]. Journal of China Pharmaceutical University, 2020, 51(6): 711-717. DOI: 10.11665/j.issn.1000-5048.20200610
    [3]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [4]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [5]YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
    [6]TANG Qian, CHEN Song, GAO Xiangdong. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 622-628. DOI: 10.11665/j.issn.1000-5048.20170519
    [7]HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
    [8]WANG Xin-ting, ZHANG Mian, GUO Hai-fang, LIU Can, HU Nan, LIU Li, LIU Xiao-dong. Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 453-459.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES FROM SPORE OF TREMELLA FUCIFORMIS BERK[J]. Journal of China Pharmaceutical University, 1988, (4): 303-304.

  • Cited by

    Periodical cited type(2)

    1. 林会平，孙国绍，梁波. 两种7-羟基香豆素衍生物的合成和NMR分析. 广州化学. 2020(01): 31-37 .
    2. 雷志伟，尹荣秀，李露露，郭灿. 香豆素类化合物合成的研究概况. 贵州茶叶. 2019(03): 18-21 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (2252) PDF downloads (1397) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：302641

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return